Prostate and Thyroid Cancers May Be Linked to HPV: Insights for Prevention

While HPV has been directly linked to cervical and some head and neck cancers, emerging evidence suggests new associations with other types of cancers.

Jezper/Shutterstock

Viruses play a significant role in the development of certain types of cancers. They can alter normal cell function by integrating their genetic material into human DNA, leading to mutations and disruptions in cell growth and division. This can cause uncontrolled cell proliferation, a hallmark of cancer.

Some viruses, like the human papillomavirus (HPV), are directly linked to specific cancers such as cervical and some head and neck cancers. As cancer research continuously evolves, new correlations between known viruses and various cancers are emerging.

Evolving Role of HPV

HPV is a contagious pathogen primarily transmitted through sexual contact, leading to HPV-related cancers in both genders. The vast majority of cervical cancers have a connection to HPV, and a growing body of evidence suggests a similar association with some head and neck cancers, particularly oropharyngeal cancer. Additionally, a range of anogenital cancers, such as vaginal, vulvar, penile, and anal cancers, also fall under the category of malignancies associated with HPV.

Recent studies have revealed a potential link between HPV infections and more significant forms of cancer. These insights challenge our current understanding of these diseases and open new avenues for prevention and treatment strategies.

HPV’s link to cervical, head, and neck cancers is well-established and supported by decades of research and clinical evidence. The virus is a significant cause of these cancers, with a clear and direct connection. However, emerging research is exploring the potential role of HPV in other cancers, such as prostate and thyroid cancers.

While initial studies suggest a possible link, the research is still in the early stages.

Prostate Cancer: The Leading Cancer in Men

The prostate is a small gland located just below the bladder in men, near the rectum. It’s shaped like a walnut and surrounds the urethra, the tube that carries urine from the bladder out through the penis. Its primary function is to produce seminal fluid, which is a component of semen. This location and function make it a vital part of the male reproductive system.

Globally, prostate cancer is the most common cancer diagnosis among men. In 2015, it accounted for around 1.6 million new cases. Over the period from 2014 to 2019, the incidence of prostate cancer exhibited a consistent annual increase of 3 percent.

U.S. projections for 2023 anticipated 288,300 new cases of prostate cancer, solidifying its status as the most prevalent cancer among males in the country. This would constitute 15 percent of all new cancer diagnoses and is associated with an estimated 34,700 deaths within the same year.

In its early stages, prostate cancer may not cause noticeable symptoms. More advanced cases can lead to issues like trouble urinating, decreased force in the urine stream, blood in urine or semen, bone pain, unintentional weight loss, and erectile dysfunction. Approximately half of the cancers were advanced.

Risk factors include older age, being black, a family history of prostate cancer, and obesity. The mortality rate of prostate cancer in blacks is two to four times higher than in other racial and ethnic groups.

HPV and Prostate Cancer

A December 2023 study published in the Nature journal Prostate Cancer and Prostatic Diseases has shed light on HPV as a new risk factor for prostate cancer.

The study utilized data from Taiwan’s Longitudinal Health Insurance Database 2010, analyzing cases of 5,137 patients with prostate cancer and 15,411 matched controls.

The findings were significant, with data indicating a markedly higher incidence (2.3 times higher) of previous HPV infections among individuals with prostate cancer compared with their control counterparts. This means that the risk of developing prostate cancer is more than double after a previous HPV infection compared with those who were never infected. Individuals diagnosed with chronic prostatitis were also at a higher risk for subsequently developing prostate cancer.

Adjustments were made for other common risk factors, including age, monthly income, geographic location, urbanization level of the patient’s residence, as well as hyperlipidemia, diabetes, hypertension and chronic prostatitis, tobacco use, and alcohol abuse.

These findings suggest that HPV might play a more fundamental role in the development of prostate cancer than previously thought.

HPV and Thyroid Cancer

More surprisingly, thyroid cancer, a less common but still potentially lethal cancer, was also related to HPV.

The thyroid is a small, butterfly-shaped gland located at the base of the neck, just below the “Adam’s apple,” the thyroid cartilage surrounding the larynx, which is typically more prominent in men than women. It plays a crucial role in the body’s metabolism, growth, and development. The thyroid gland produces thyroid hormones that regulate various bodily functions, including heart rate, body temperature, and how the body uses energy. These hormones are essential for the proper functioning of nearly every body part.

Thyroid cancer is the most prevalent cancer of the endocrine system. In recent years, the incidence of thyroid cancer in the United States has significantly increased, tripling over the past 30 years. Currently, around 45,000 new cases are diagnosed each year.

Another groundbreaking study in Nature published in January focused on the association between HPV and thyroid cancer.

This research involved a comprehensive case-control study using Taiwan’s Longitudinal Health Insurance Database 2010, including 3,062 patients with thyroid cancer and 9,186 propensity-scored matched controls. The propensity score balances an observational study by using some of the study characteristics to mimic a randomized controlled trial.

The study’s results were startling: The research suggests a significant link between HPV and the development of thyroid cancer. People with a prior HPV infection have almost twice the chance of developing thyroid cancer compared with those without a prior infection, with similar findings in males and females.

The results remained the same regardless of age, sex, income, and other key attributes, suggesting a fundamental biological association between the virus and its cancer-inducing outcome.

Cancer-Causing Mechanisms

While these studies provide compelling evidence of the association between HPV and both prostate and thyroid cancers, it’s essential to understand the underlying mechanisms. There are several mechanisms through which HPV contributes to the development of these cancers.

Harmful genetic and environmental elements can increase the risk of developing cancer. However, our immune system can monitor and kill cancer cells as soon as the malignant cells appear. Ultimately, the strength of our immune system determines if we contract cancer or not and how fast it will spread if we do, which depends on our body’s ability to fight cancer cells effectively.

Genetic mutations in specific cancer-related genes commonly lead to abnormal cell growth and tumor formation. Environmental risk factors include ionizing radiation. Nutritional factors, including iodine deficiency or excess, can increase the risk of developing thyroid cancer.

The role of HPV in causing cancer is primarily due to its critical cancer-inducing proteins, E6 and E7. These proteins break down the body’s tumor-fighting proteins (p53 and pRb). This breakdown interferes with the standard control of cell growth, leading to rapid and uncontrolled cell multiplication.

Additionally, E6 and E7 interfere with other cell functions, such as DNA repair and blood vessel growth, and hinder the cell’s natural self-destruction, termed “apoptosis,” which can lead to increased genetic instability and potential cancer.

Can the HPV Vaccine Prevent These Cancers?

The potential link between HPV and these cancers has profound implications. Exploring possible preventive measures could be a significant step forward in cancer prevention.

Some people have proposed expanding the use of HPV vaccines to include protection against these types of cancers. While this may appear to be a reasonable assumption given the current belief that the HPV vaccine adequately prevents cervical cancer, the battle between the virus and vaccine technology has proven to be more complex than most people realize. Viruses are a group of microscope organisms with a profound ability to escapeeven our most advanced vaccine technology.

For example, in the case of cervical cancer, the HPV vaccine does not cover all high-risk HPV types. Of the over 200 HPV strains, 22 pose a high risk for cervical cancer, yet Gardasil 9 targets less than half of these high-risk strains. This limitation may lead to the prevalence of other dangerous strains. Studies have observed shifts in HPV strain prevalence post-vaccination, with some non-vaccine high-risk strains becoming more common, particularly in vaccinated individuals.

Furthermore, the vaccine bypasses our mucosal immunity, resulting in an unbalanced stimulation of our immune system which may not favor our body’s holistic fight against cancer.

HPV vaccines do not cover all HPV strains that cause cervical cancer and will induce changes in cervical HPV strains. Illustration by The Epoch Times

The Role of Natural Immunity in Eradicating Cancer

Our body’s natural immunity serves to combat viruses and, therefore, plays a crucial role in fighting against cancer.

This natural defense mechanism is equipped to detect and eliminate cancer cells. Enhancing our natural immunity strengthens our ability to recognize and respond to cancerous cells early, thereby preventing the development of cancer.

Eating healthy food, maintaining quality sleep and a healthy weight, exercising, and using stress-reduction techniques, including mindfulness and meditation, all help enhance our natural immunity and reduce cancer risks.

Controlled Sexual Behavior Reduces Cancer Risk

Controlled sexual behaviors are known to be protective against cervical cancer, including older age at first sexual activity and limited sexual partners.

Engaging in sex for the first time on or before age 16 or between 17 to 20 years of age increased the risk of developing invasive cervical cancer by 2.3 and 1.8 times, respectively, compared with women over age 21. Illustration by The Epoch Times

In the case of prostate cancer, research also suggests a possible link between sexual activity and increased cancer risk.

A systematic review analyzing 21 case-control studies and one cohort study of 55,490 male participants (14,976 patients and 40,514 controls) explored how prostate cancer risk was affected by the number of female sexual partners, the age at first sexual intercourse, and the ejaculation frequency.

The researchers found that having more female sexual partners slightly increased the risk of prostate cancer. Delaying the age of first intercourse reduced this risk by 4 percent for every five-year delay. Moderate frequency of ejaculation, defined as two to four times per week, was significantly associated with a lower risk of prostate cancer.

For thyroid cancer, there is no biomedical study that directly establishes a link between sexual behavior and the risk of developing this type of cancer. However, limiting the number of sexual partners and delaying the age of first sex would reduce the risk of HPV infection. As HPV is carcinogenic, the less HPV we have in our body, the less likely we will develop a related cancer.

Sexual behavior, including the age of first sexual activity and the number of sexual partners, is relevant in cancer prevention in theory based on the established research findings regarding the interplay between HPV, sexual activity, and cancer.

Future Perspective on HPV and Cancer

The revelations from these newly published studies suggest that the impact of HPV infection extends far beyond the commonly known associations with cervical and head or neck cancers.

By shedding light on its potential role in prostate and thyroid cancers, these findings challenge the medical community to broaden its perspective on HPV. It’s possible that other cancers may also be influenced by HPV and sexual behavior. Future research may reveal more profound underlying mechanisms.

As research continues to unveil the multifaceted nature of HPV, it becomes increasingly clear that our understanding and management of this virus are crucial to the broader fight against cancer. This could lead to the development of comprehensive educational health programs that ultimately contribute to reducing the incidence and mortality rates associated with these and other cancers.

Last but not least, our choices matter; traditional values can help us live healthier.

Views expressed in this article are the opinions of the author and do not necessarily reflect the views of The Epoch Times. Epoch Health welcomes professional discussion and friendly debate. To submit an opinion piece, please follow these guidelines and submit through our form here.